Very recently, Cattaneo et al. used a shortened version of the CaMKII promoter (mCamk2a, 0.4 kb) to express NPY and its receptor Y2R in an LV vector for treating epilepsy in the synapsin triple knockout model in mice. This evidence concerns the gene CAMK2G and epilepsy.